AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03719235 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CBCT
Description: ultra-low dose CBCT
Study NCT02197377 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Group LMA Unique™
Description: The supraglottic airway devices were deflated fully before insertion. After placement an effective airway was defined as the presence of normal thoracoabdominal movement and a square-wave end-tidal carbon dioxide trace.
Study NCT02197377 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group LMA Supreme™
Description: The supraglottic airway devices were deflated fully before insertion.The supraglottic airway devices were deflated fully before insertion. After placement an effective airway was defined as the presence of normal thoracoabdominal movement and a square-wave end-tidal carbon dioxide trace.
Study NCT02076165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and the Behavioral Changes to Treat Insomnia
Description: Participants attended 5 individual sessions incorporating behavioral treatment components plus acceptance and commitment therapy (ACT) with a trained instructor.
Study NCT02076165 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy for insomnia
Description: Participants attended 5 individual sessions incorporating behavioral and cognitive therapy components with a trained instructor.
Study NCT01135732 — intervention group
Intervention type: PROCEDURE
Intervention: brush cytology
Description: brush cytology during ERCP
Study NCT03893045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ferumoxytol
Description: Each 20 mL single-use vial contains 17 mL of ferumoxytol that consists of iron at a concentration of 30 mg Fe/mL, coated with polyglucose sorbitol carboxymethylether and formulated with mannitol, at a concentration of 44 mg/mL, in a black to reddish brown sterile, aqueous, colloidal, isotonic solution
Study NCT03893045 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iron sucrose
Description: Each mL contains 20 mg of elemental iron as iron sucrose in water for injection. The 5 mL single-use vial contains 100 mg of iron per 5 mL. The drug product contains approximately 30% sucrose (300 mg/mL).
Study NCT03625531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Women in both personalized and fixed acupuncture groups will receive acupuncture treatment three times a week. Acupuncture treatment will start on day 3 after a spontaneous period or after a withdrawal bleeding following progestin. Each treatment session will last for 30-60 minutes, with a maximum of 48 treatment sessions over 16 weeks. If they become pregnant, the acupuncture treatment will be stopped. For personalized and fixed acupuncture group, credibility and expectancy questionnaires will be completed on the third acupuncture treatment and the last acupuncture treatment.
Study NCT03625531 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole
Description: Letrozole will be started on day 3 to day 7 of the spontaneous period or a withdrawal bleeding following progestin. If there is response with ovulation, this dose will be maintained. In those with no ovulatory response, letrozole tablets of the next ovulation cycle will be take on the day 28 of the menstrual cycle and the letrozole dose will be increased to 5 mg (2 pills) a day for 5 days. If there is still no response, the dose will be increased to 7.5 mg per day for 5 days in the next cycle. The maximum daily dose of letrozole will be 7.5 mg (3 pills) daily for five days.
Study NCT03625531 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo letrozole
Description: Placebo letrozole will be given in the same way as letrozole. Women will receive 1 tablet a day of placebo letrozole from the day 3 to day 7 of the menstrual cycle and placebo letrozole dose will be increased 2 tablets a day in the next cycle if there is no response. The maximum daily dose of placebo letrozole will be 3 tablets daily for five days.
Study NCT03017209 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Locally-prepared bar
Description: School children in first grade will receive their supplement 5 days a week in the morning before school starts. Younger children will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers. The teachers and community health workers will record amount of supplement consumption daily during the study, and will report the information weekly to the local research team throughout the intervention period.
Study NCT03017209 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: USAID Corn Soy Blend Plus
Description: School children in first grade will receive their supplement 5 days a week in the morning before school starts. Younger children will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers. The teachers and community health workers will record amount of supplement consumption daily during the study, and will report the information weekly to the local research team throughout the intervention period.
Study NCT03017209 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: School children in first grade will receive their supplement 5 days a week in the morning before school starts. Younger children will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers. The teachers and community health workers will record amount of supplement consumption daily during the study, and will report the information weekly to the local research team throughout the intervention period.
Study NCT03157362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Near Non-Social
Description: Participants will be stably seated, and observed by a research assistant, as they complete an induced pain threshold task while they experience a virtual environment that reproduces the room in which they are seated.
Study NCT05037604 — intervention group
Intervention type: OTHER
Intervention: Questionnaire about associated factors
Description: Questionnaire about age, prolonged sun exposure, intake of anticoagulants / antiplatelets, intake of oral steroids, chronic kidney disease. Maternal age> 40 years in their last child , time of lactation per pregnancy and cumulative time of lactation. Age of the first pregnancy and age of menopause onset.
Study NCT02006771 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Southern Chinese meal
Description: White rice (1 bowl), stir fried choi sum (0.5 bowl) and stir fried lean pork (0.5 bowl) cooked with maize oil
Study NCT02006771 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Northern Chinese meal
Description: Noodles (1 bowl) and shredded pork with sweet bean sauce (0.5 bowl) cooked with blend oil
Study NCT02006771 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: American meal
Description: Hamburger with cheese (1 piece), French fries (117 g) cooked with canola blend oil and Coca-cola classic (21 fluid ounces)
Study NCT02006771 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: South Indian meal
Description: Basmati rice (1 bowl), chicken curry dish (0.5 bowl), dry vegetable dish (i.e. green beans mixed with herbs) (0.5 bowl), yogurt made with milk powder mainly (0.5 bowl), pickle made with lemon, salt, chilli powder, Asafoetida and vegetable based oil (1 tablespoon)
Study NCT01371461 — intervention group
Intervention type: DRUG
Intervention: Paroxetine
Study NCT02537041 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: elastography function ShearWave Imaging
Description: non-invasive assessment of myocardial stiffness by elastography
Study NCT02537041 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: MRI
Study NCT04402047 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: We will apply Ashi points, Ex-UE9, SI3, and TE5. Sterile needles (0.3mm× 40mm) and SDZ-V EA apparatus will be utilized. Acupuncturists will insert needles perpendicularly into Ashi points for approximately 2-3mm until they pierce into the bone surface; acupuncturists will insert needles horizontally into Baxie points towards the wrist with a depth of 5-10mm; and acupuncturists will insert needles perpendicularly into SI3 and TE5 for approximately 5-10mm. All needles except Ashi points will be manually manipulated to achieve De qi. The needles at Baxie 1 and Baxie 4 will be connected using alligator clips from the EA apparatus. The electrical stimulation will last for 30 minutes with a continuous wave of 10 Hz and a fixed current intensity of 0.5 to 2 mA. All the needles will be retained for 30 minutes. Participants will undergo EA treatment three times per week for a total of 12 sessions in four consecutive weeks. If bilateral hands were affected, both sides will be treated.
Study NCT04402047 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical diclofenac sodium gel
Description: The gel will be gently rubbed over the affected joints without excessive joint movement four times per day for 4 weeks and will be asked not to wash hands for one hour after application. Each hand treatment will be used in identical dispensing doses of gel (4 cm strip, approximately 2g, which was judged sufficient for approximately half the surface of each hand (200 cm2)). Dosing times should be distributed evenly over waking hours.If bilateral hands were affected, both sides will be treated.
Study NCT04004949 — intervention group
Intervention type: OTHER
Intervention: Assessment of scapular balance angle and upper extremity sensorimotor function
Description: The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores \& scapular balance angle test (SBA).
Study NCT01907620 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: blood sample
Study NCT02484027 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Rosuvastatin
Description: Patients will be randomly assigned to receive 2 different therapies for the first 3 days of hospitalization: no statins (non-statin-therapy group) or to immediately receive rosuvastatin orally at a dose of 20mg daily (statin-therapy group). From the fourth day onward, rosuvastatin 10 mg daily will be administered in all patients for 1 year
Study NCT02484027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Patients will be randomly assigned to receive 2 different therapies for the first 3 days of hospitalization: no statins (non-statin-therapy group) or to immediately receive rosuvastatin orally at a dose of 20mg daily (statin-therapy group). From the fourth day onward, rosuvastatin 10 mg daily will be administered in all patients for 1 year
Study NCT05075668 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP face mask
Description: Two types of CPAP therapy for OSA support are compared; CPAP face mask vs HFNC at different flow rates
Study NCT05075668 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High flow nasal cannula (HFNC)
Description: Two types of CPAP therapy for OSA support are compared; CPAP face mask vs HFNC at different flow rates
Study NCT00747487 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idebenone
Description: Idebenone 900 mg/day
Study NCT00747487 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02763956 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GelStix™ Nucleus Augmentation Device
Description: Intradiscal Gelstix insertion
Study NCT02763956 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intradiscal saline injection
Study NCT03367871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV
Study NCT03367871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Administered intravenously (IV) on day 1
Study NCT03367871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered intravenously (IV) on day 1
Study NCT03367871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered intravenously (IV) on day 1
Study NCT03367871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Administered intravenously (IV) on day 1
Study NCT00692367 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Physical Activity
Description: 1. Physical activity group: Subjects will be progressed to 4-5 days per week, 30-45 min per session (120-180 min per week) of moderate intensity exercise. 2. Control (educational) group: Subjects will receive their usual care following surgery that in addition to their weight loss.
Study NCT04343950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminders to enhance colorectal cancer screening
Description: Cluster randomization instead of individual randomization will be used. The cluster will be invitation week.~Individuals assigned to the experimental arm with a wrong phone number will get a reminder letter (protocol analysis).
Study NCT04343950 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SMS reminders to enhance colorectal cancer screening
Description: Cluster randomization instead of individual randomization will be used. The cluster will be invitation week.~Individuals assigned to the experimental arm with a wrong phone number will get a reminder letter (protocol analysis).
Study NCT04343950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening:
Description: Cluster randomization instead of individual randomization will be used. The cluster will be invitation week.~Individuals with a wrong phone number assigned to the experimental arm will not get any reminder (protocol analysis).
Study NCT04343950 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening:
Description: Cluster randomization instead of individual randomization will be used. The cluster will be invitation week.~Individuals with a wrong phone number assigned to the experimental arm will not get any reminder (protocol analysis).
Study NCT04343950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Invitation by SMS to previous participants in breast cancer screening:
Description: Individual randomization. Women assigned to the experimental arm and with a wrong phone number will get an invitation letter (protocol analysis).
Study NCT04343950 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Invitation by SMS to previous participants in breast cancer screening:
Description: Individual randomization. Women assigned to the experimental arm and with a wrong phone number will get an invitation letter (protocol analysis).
Study NCT05289960 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: lung ultrasound
Description: Lung ultrasound score was done at the end of SBT using curved array ultrasound probe 2-5 MHz, Siemens X300, Korea
Study NCT02325544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: 12 sessions of CBT (over 4-5 months) +1 booster session. Guided by a therapy manual and patient handouts; will involve setting homework tasks. Although treatment is manualised, it allows treatment to be formulation-based i.e. tailored to the person.~Standardised medical as described in other intervention.
Study NCT02325544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized Medical Care
Description: Delivered by neurologists/ psychiatrists - both will be involved in discussing diagnosis. It will Include an information sheet about dissociative seizures and direction to self-help websites, general information provision about management of DS and support, consideration of psychiatric comorbidities / associated drug treatment and general review but no CBT techniques.
Study NCT02325544 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Medical Care
Description: Delivered by neurologists/ psychiatrists - both will be involved in discussing diagnosis. It will Include an information sheet about dissociative seizures and direction to self-help websites, general information provision about management of DS and support, consideration of psychiatric comorbidities / associated drug treatment and general review but no CBT techniques.
Study NCT04278911 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MMSE and MoCA
Description: This is an observational study. All the patients evaluate with MMSE (Mini-mental State Examination) and MoCA (Montreal Cognitive Assessment), and investigate the incidence and characteristics of cognitive and MACE
Study NCT01976949 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: online social-networking intervention
Study NCT02706938 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Head of bed elevation
Description: Head of bed elevation will be achieved with a pair of prisms of withered pine tree wood with dimensions (Height x Width x Depth) 20x18x18 cm. Each prism lying on the floor will support one of the head legs of the bed
Study NCT02706938 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard treatment
Description: Standard pharmacological treatment with a proton pump inhibitor and/or sodium alginate, according to clinical judgement.
Study NCT03954626 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: brolucuzumab 6 mg IVT
Description: Single intravitreal injection (IVT) of brolucizumab 6 mg
Study NCT00750984 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anterolateral approach
Description: The anterolateral approach is performed with the patient positioned on the side. The blood supply to the femoral neck from the medial circumflex artery is regarded preserved by this surgical method.
Study NCT00750984 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior approach
Description: The posterior approach is performed with the patient positioned on the side. The medial circumflex artery is cut at the lower border of the short external rotators risking a compromised blood supply to the femoral head.
Study NCT00750984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReCap Total Hip Resurfacing
Description: This arm utilizes the anterolateral approach using the ReCap® Total Hip Resurfacing System.
Study NCT00750984 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReCap Total Hip Resurfacing
Description: This arm utilizes the posterior approach using the ReCap® Total Hip Resurfacing System.
Study NCT03824301 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Volume controlled ventilation
Description: Changing modes of ventilation during cardiopulmonary bypass
Study NCT03824301 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pressure controlled ventilation
Description: Applying pressure controlled ventilation during cardiopulmonary bypass Period
Study NCT03157362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Near Social
Description: Participants will be stably seated, and observed by a research assistant, as they complete an induced pain threshold task while they experience a virtual environment that reproduces the room in which they are seated, and converse with a confederate represented by an avatar.
Study NCT01718977 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Arm Cycle Ergometry Training
Description: Arm Cycle Ergometry Training ACET will be performed on an arm-cycle ergometer against individually determined levels of resistance. Upright hand cuffs will be used so that the hand will be placed with the thumb pointing downward, and the ergometer will be positioned so that the arm never exceeded the height of the shoulder.~The end objective is for the individual to complete 30-minutes of exercise in 2, 15-minute bouts. For safety reasons, stop criteria for individual sessions will be set and participants will have a rest period of 5 minutes and afterwards asked if they want to stop exercise, or resume the session.
Study NCT02749214 — intervention group
Intervention type: OTHER
Intervention: Blood Sample Collection
Description: Participants will have two to three tablespoons (30 cc) of peripheral blood drawn to test for inflammatory markers.
Study NCT02749214 — intervention group
Intervention type: OTHER
Intervention: Breath Sample Collection
Description: Participants will be asked to breathe into the Breath Sampler containing a rapid passive volatile organic compounds (VOC) sampling device. A disposable mouthpiece is placed over a portion of the sampler where the participant placed his/her mouth. The mouthpiece will be disposed of after each use and a new one will be used for each participant. Prior to sample collection, the participant will be asked to rinse his/her mouth with water. Then the participant will breathe deeply into the sampler five times with breaths being five minutes apart to collect the alveolar breath.
Study NCT03157362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Far Non-Social
Description: Participants will be stably seated, and observed by a research assistant, as they complete an induced pain threshold task while they experience a virtual environment that reproduces a different room.
Study NCT03157362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Far Social
Description: Participants will be stably seated, and observed by a research assistant, as they complete an induced pain threshold task while they experience a virtual environment that reproduces another room, and converse with a confederate represented by an avatar.
Study NCT05107323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Compassionate Mind Training for Teachers
Description: Compassionate Mind Training for Teachers is a biopsychosocial evidence-based approach that aims to foster compassion, affect regulation, prosocial qualities and wellbeing in teachers.
Study NCT04607863 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Case control
Description: Is a case-control research